官方服务：
资源简介：
Percentage of EDSSp 6.5+ by group.
应用场景：
创建时间：
2014-06-02
相关数据集
A survey of risk tolerance to multiple sclerosis therapies
Objective: To determine tolerance to various risk scenarios associated with current MS therapies. Methods: People with MS from the North American Research Committee on Multiple Sclerosis (NARCOMS) Re
DataONE2020-06-24 更新70
Relationship between level of disability, bladder dysfunction, bowel dysfunction, and fatigue.
EDSS: Expanded Disability Status Scale (range 1–10); MFIS: Modified Fatigue Impact Scale (range 1–84); ABSST: Actionable Bladder Symptom Screening Tool (range 1–24); RFIS: Revised Faecal Incontinence
NIAID Data Ecosystem60
Participant profiles in the four groups.
+: EPDS>8, −: EPDST1: early pregnancy (before 25 weeks).late: late pregnancy (around 36 weeks).T2: postpartum (1 month).a: ANOVA was used to test the mean differences of age within the four groups.
Figshare2015-12-02 更新60
Comparisons of the mean of EDSSp post-interferon-β therapy between groups.
Comparisons of the mean of EDSSp post-interferon-β therapy between groups.
NIAID Data Ecosystem70
Comparison of time to clinically meaningful improvement in quality of life in neurological disorders in patients treated with natalizumab versus ocrelizumab
Aim: To assess time to improvement in Quality of Life in Neurological Disorders (Neuro-QoL) domains for patients treated with natalizumab versus ocrelizumab. Methods: Patients enrolled in the MS PATHS
Figshare2024-04-16 更新60
